Coronaviruses are enveloped non-segmented positive-sense RNA viruses infecting humans & vertebrates’ respiratory, gastrointestinal, hepatic & CNS.
Latest Insights & Products for SARS-CoV-2/COVID-19 Research
Cytokine Storm and Severity of COVID-19
The most critically ill COVID-19 patients undergo a cytokine storm leading to poor prognosis & need urgent anti-inflammatory treatment/hospitalisation.
Antiviral Compounds – Potential Small Molecule Therapeutics Against COVID-19
AdipoGen Life Sciences offers a Selection of Antiviral Small Molecules as Potential Tools for in vitro Studies of COVID-19 (not for human use).
All Human ACE2 Antibodies
List of all AdipoGen Life Sciences’ Human ACE2 Antibodies
UNIQUE Human ACE2 Monoclonal Blocking Antibody
Anti-ACE2 (human), mAb (blocking) (AC384) (preservative free) is a monoclonal antibody that recognises human ACE2 and blocks its binding to SARS-Cov-2.
SARS-CoV-2 Inhibitor Screening Set
AdipoGen’s SARS-CoV-2 Inhibitor Screening Set has been developed as a HTS detection assay for the determination of SARS-CoV-2 blocking reagents.
COVID-19 Diagnostics
AdipoGen has detection of soluble ACE2, antibodies against SARS-CoV-2 and a HTS detection kit for the determination of SARS-CoV-2 blocking reagents.
Biological Therapeutic Strategies against SARS-CoV-2 and COVID-19
To date, there are no effective vaccines against coronavirus, which can cause pneumonia & bronchitis, but several strategies are being pursued.
ACE2 & Functional Receptor for SARS Coronaviruses
ACE2 was identified as a key receptor on target cells for SARS-CoV in 2002. ACE2 is the entry receptor of SARS-CoV-2 & is the cause of COVID-19.
Mobilised LeukoPak Collections
Caltag Medsystems offers Mobilised LEUKOMAX® Leukopak units from healthy, normal human donors. Through the process, donors are prepped with injections of G-CSF (Granulocyte-Colony Stimulating Factor – also known as Neupogen®), Plerixafor (also known as Mozobil®) or a combination of the